BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 6290540)

  • 1. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly.
    Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
    Nasr C; Mason A; Mayberg M; Staugaitis SM; Asa SL
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4776-80. PubMed ID: 16968791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
    Ezzat S; Asa SL; Stefaneanu L; Whittom R; Smyth HS; Horvath E; Kovacs K; Frohman LA
    J Clin Endocrinol Metab; 1994 Mar; 78(3):555-60. PubMed ID: 8126126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor.
    Wilson DM; Ceda GP; Bostwick DG; Webber RJ; Minkoff JR; Pont A; Hintz RL; Bensch KG; Kraemer FB; Rosenfeld RG
    J Clin Endocrinol Metab; 1984 Nov; 59(5):1002-5. PubMed ID: 6090497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Draznin MB; Johanson AJ; Rogol AD; Jane JA; Rudolf LE; Horvath E; Kovacs K; Vale W
    Trans Assoc Am Physicians; 1982; 95():177-87. PubMed ID: 6304974
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly.
    Frohman LA; Szabo M; Berelowitz M; Stachura ME
    J Clin Invest; 1980 Jan; 65(1):43-54. PubMed ID: 6243140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic growth hormone-releasing hormone (GHRH) syndrome in a case with multiple endocrine neoplasia type I.
    Yamasaki R; Saito H; Sano T; Kameyama K; Yoshimoto K; Hosoi E; Matsumura M; Harada K; Saito S
    Endocrinol Jpn; 1988 Feb; 35(1):97-109. PubMed ID: 2899505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly, diabetes insipidus, and visual loss caused by metastatic growth hormone-releasing hormone-producing malignant pancreatic endocrine tumor in the pituitary gland. Case report.
    Genka S; Soeda H; Takahashi M; Katakami H; Sanno N; Osamura Y; Fuchinoue T; Teramoto A
    J Neurosurg; 1995 Oct; 83(4):719-23. PubMed ID: 7674023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
    Wilson DM; Hoffman AR
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
    Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly.
    Hulting AL; Wersäll J; Werner S
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone.
    Weiss DE; Vogel H; Lopes MB; Chang SD; Katznelson L
    Endocr Pract; 2011; 17(1):79-84. PubMed ID: 20713338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin releasing hormone (TRH)-induced release of 7B2 (neuroendocrine polypeptide) in vivo and in vitro using adenoma cells of a patient with acromegaly.
    Natori S; Iguchi H; Ohashi M; Kitamoto T; Chrétien M; Nawata H
    Jpn J Med; 1991; 30(3):208-12. PubMed ID: 1920959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.
    Lamberts SW; Verleun T; Oosterom R
    J Clin Endocrinol Metab; 1984 Feb; 58(2):250-4. PubMed ID: 6141175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor.
    Ezzat S; Ezrin C; Yamashita S; Melmed S
    Cancer; 1993 Jan; 71(1):66-70. PubMed ID: 8416728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly with normal growth-hormone levels and pituitary histology. Case report.
    Feingold KR; Goldfine ID; Weinstein PR
    J Neurosurg; 1979 Apr; 50(4):503-7. PubMed ID: 106097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.